ESMO26: Clinical progress shifts a historically difficult pancreatic cancer landscape
Pancreatic cancer has historically presented a poor clinical outlook, offering patients few effective therapeutic options. Because the disease rarely causes…
News
ESMO26: MSD and Moderna drop cancer vaccine trial data early
AbbVie’s skin disease drug posts Phase III win as market competition heats up
Prilenia and Ferrer secure EU authorisation for Phase III HD trial
Granata Bio concludes screening in Phase III GRACE trial for IVF
Roivant eyes Lisraya label expansion on Phase III uveitis win
HealthBio begins multi-centre trial of Inflamexa for PTLDS
Lynch’s rhPDGF-BB IND secures FDA clearance for Phase II trial
